Table of Content

1.Oncology Drugs Market Report Introduction
2.Oncology Drugs Market Executive Summary
2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
2.4. Financial Benchmarking

3. Regulatory and Patent Analysis
3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. Oncology Drugs Market Key Factors Analysis
4.1. Oncology Drugs Market Drivers
4.1.1. Increasing Incidence of Various Cancers
4.1.2. Rise in External Factors Contributing in Cancer Development
4.1.3. Growing Popularity of Precision Medicine and Targeted Therapy
4.1.4. Technological Advancements in Product Development
4.2. Oncology Drugs Market Restraints and Challenges
4.2.1. Potential Side-Effects Associated with Cancer Therapies
4.2.2. High Cost of Oncology Drugs
4.3. Oncology Drugs Market Opportunities
4.3.1. Improving Affordability of Cancer Therapies
4.3.2. Development of Safer Cancer Therapies with Minimal Side-Effects

5. Oncology Drugs Market Porter’s Five Forces Analysis
5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Oncology Drugs Market

7. Oncology Drugs Market Layout
7.1. By Therapy Type
7.1.1. Chemotherapy
7.1.2. Hormonal Therapy
7.1.3. Targeted Therapy
7.1.3.1. Gene Therapy
7.1.3.2. Immunotherapy
7.1.4. Others
7.2. By Cancer Type
7.2.1. Breast Cancer
7.2.2. Lung Cancer
7.2.3. Prostate Cancer
7.2.4. Blood Cancers
7.2.5. Others
7.3. By End User
7.3.1. Hospitals
7.3.2. Specialty Clinics
7.3.3. Others
7.4. By Geography
7.4.1. North America
7.4.1.1. North America Oncology Drugs Market, by Country
7.4.1.4.1. United States
7.4.1.4.2. Canada
7.4.1.4.3. Mexico
7.4.2. Europe
7.4.2.1. Europe Oncology Drugs Market, by Country
7.4.2.4.1. France
7.4.2.4.2. Germany
7.4.2.4.3. United Kingdom
7.4.2.4.4. Italy
7.4.2.4.5. Spain
7.4.2.2.6. Russia
7.4.2.2.7. Rest of Europe
7.4.3. Asia-Pacific
7.4.3.1. Asia-Pacific Oncology Drugs Market, by Country
7.4.3.4.1. China
7.4.3.4.2. Japan
7.4.3.4.3. India
7.4.3.4.4. Australia
7.4.3.4.5. South Korea
7.4.3.4.6. Rest of Asia Pacific
7.4.4. Rest of the World (RoW)
7.4.4.1. RoW Oncology Drugs Market, by Region
7.4.4.4.1. Middle East
7.4.4.4.2. Africa
7.4.4.4.3. South America

8. Oncology Drugs Market Global Company Share Analysis – Key 3-5 Companies

9. Oncology Drugs Market Company and Product Profiles
9.1. GlaxoSmithKline
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Financial Overview
9.1.4. Product Listing
9.1.5. Entropy
9.2. Eli Lilly & Company
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Financial Overview
9.2.4. Product Listing
9.2.5. Entropy
9.3. F. Hoffmann-La Roche Ltd,
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Financial Overview
9.3.4. Product Listing
9.3.5. Entropy
9.4. AbbVie Inc.
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Financial Overview
9.4.4. Product Listing
9.4.5. Entropy
9.5. Amgen Inc.
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Financial Overview
9.5.4. Product Listing
9.5.5. Entropy
9.6. Sanofi
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Financial Overview
9.6.4. Product Listing
9.6.5. Entropy
9.7. Merck & Co., Inc.
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Financial Overview
9.7.4. Product Listing
9.7.5. Entropy
9.8. Novartis AG
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Financial Overview
9.8.4. Product Listing
9.8.5. Entropy
9.9. Pfizer Inc.
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Financial Overview
9.9.4. Product Listing
9.9.5. Entropy
9.10. AstraZeneca
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Financial Overview
9.10.4 Product Listing
9.10.5. Entropy
9.11. Bristol Myers Squibbs
9.11.1. Company Overview
9.11.2. Company Snapshot
9.11.3. Financial Overview
9.11.4. Product Listing
9.11.5. Entropy
9.12. Gilead Sciences, Inc.
9.12.1. Company Overview
9.12.2. Company Snapshot
9.12.3. Financial Overview
9.12.4. Product Listing
9.12.5. Entropy
9.13. Janssen Global Services, LLC
9.13.1. Company Overview
9.13.2. Company Snapshot
9.13.3. Financial Overview
9.13.4. Product Listing
9.13.5. Entropy
9.14. BAYER AG
9.14.1. Company Overview
9.14.2. Company Snapshot
9.14.3. Financial Overview
9.14.4. Product Listing
9.14.5. Entropy
9.15. Celldex Therapeutics Inc
9.15.1. Company Overview
9.15.2. Company Snapshot
9.15.3. Financial Overview
9.15.4. Product Listing
9.15.5. Entropy
9.16. Alaunos Therapeutics, Inc.,
9.16.1. Company Overview
9.16.2. Company Snapshot
9.16.3. Financial Overview
9.16.4. Product Listing
9.16.5. Entropy
9.17. Astellas Pharma Inc
9.17.1. Company Overview
9.17.2. Company Snapshot
9.17.3. Financial Overview
9.17.4. Product Listing
9.17.5. Entropy
9.18. Genentech Inc
9.18.1. Company Overview
9.18.2. Company Snapshot
9.18.3. Financial Overview
9.18.4. Product Listing
9.18.5. Entropy
9.19. Sandoz International GmbH
9.19.1. Company Overview
9.19.2. Company Snapshot
9.19.3. Financial Overview
9.19.4. Product Listing
9.19.5. Entropy
9.20. BeiGene
9.20.1. Company Overview
9.20.2. Company Snapshot
9.20.3. Financial Overview
9.20.4. Product Listing
9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us



List of Figures

Figure 1: Competitive Analysis
Figure 2: COVID-19 Impact Analysis on Oncology Drugs Market
Figure 3: Oncology Drugs Market in Global (2019-2027)
Figure 4: Oncology Drugs Market in Global by Therapy Type (2019-2027)
Figure 5: Oncology Drugs Market in Global by Cancer Type (2019-2027)
Figure 6: Oncology Drugs Market in Global by End User (2019-2027)
Figure 7: Oncology Drugs Market in Global by Geography (2019-2027)
Figure 8: Oncology Drugs Market in North America (2019-2027)
Figure 9: Oncology Drugs Market in North America by Country (2019-2027)
Figure 10: Oncology Drugs Market in the US (2019-2027)
Figure 11: Oncology Drugs Market in Canada (2019-2027)
Figure 12: Oncology Drugs Market in Mexico (2019-2027)
Figure 13: Oncology Drugs Market in Europe (2019-2027)
Figure 14: Oncology Drugs Market in Europe by Country (2019-2027)
Figure 15: Oncology Drugs Market in France (2019-2027)
Figure 16: Oncology Drugs Market in Germany (2019-2027)
Figure 17: Oncology Drugs Market in the United Kingdom (2019-2027)
Figure 18: Oncology Drugs Market in Italy (2019-2027)
Figure 19: Oncology Drugs Market in Spain (2019-2027)
Figure 20: Oncology Drugs Market in Russia (2019-2027)
Figure 21: Oncology Drugs Market in Rest of Europe (2019-2027)
Figure 22: Oncology Drugs Market in APAC (2019-2027)
Figure 23: Oncology Drugs Market in APAC by Country (2019-2027)
Figure 24: Oncology Drugs Market in China (2019-2027)
Figure 25: Oncology Drugs Market in Japan (2019-2027)
Figure 26: Oncology Drugs Market in India (2019-2027)
Figure 27: Oncology Drugs Market in Australia (2019-2027)
Figure 28: Oncology Drugs Market in South Korea (2019-2027)
Figure 29: Oncology Drugs Market in Rest of APAC (2019-2027)
Figure 30: Oncology Drugs Market in Rest of World (2019-2027)
Figure 31: Oncology Drugs Market in RoW by Region (2019-2027)
Figure 32: Oncology Drugs Market in Middle East (2019-2027)
Figure 33: Oncology Drugs Market in Africa (2019-2027)
Figure 34: Oncology Drugs Market in South America (2019-2027)
Figure 35: Market Drivers
Figure 36: Market Barriers
Figure 37: Marker Opportunities
Figure 38: PORTER’S Five Force Analysis

List of Tables

Table 1: Competitive Analysis
Table 2: COVID-19 Impact Analysis on Oncology Drugs Market
Table 3: Oncology Drugs Market in Global (2019-2027)
Table 4: Oncology Drugs Market in Global by Therapy Type (2019-2027)
Table 5: Oncology Drugs Market in Global by Cancer Type (2019-2027)
Table 6: Oncology Drugs Market in Global by End User (2019-2027)
Table 7: Oncology Drugs Market in Global by Geography (2019-2027)
Table 8: Oncology Drugs Market in North America (2019-2027)
Table 9: Oncology Drugs Market in North America by Country (2019-2027)
Table 10: Oncology Drugs Market in the US (2019-2027)
Table 11: Oncology Drugs Market in Canada (2019-2027)
Table 12: Oncology Drugs Market in Mexico (2019-2027)
Table 13: Oncology Drugs Market in Europe (2019-2027)
Table 14: Oncology Drugs Market in Europe by Country (2019-2027)
Table 15: Oncology Drugs Market in France (2019-2027)
Table 16: Oncology Drugs Market in Germany (2019-2027)
Table 17: Oncology Drugs Market in the United Kingdom (2019-2027)
Table 18: Oncology Drugs Market in Italy (2019-2027)
Table 19: Oncology Drugs Market in Spain (2019-2027)
Table 20: Oncology Drugs Market in Russia (2019-2027)
Table 21: Oncology Drugs Market in Rest of Europe (2019-2027)
Table 22: Oncology Drugs Market in APAC (2019-2027)
Table 23: Oncology Drugs Market in APAC by Country (2019-2027)
Table 24: Oncology Drugs Market in China (2019-2027)
Table 25: Oncology Drugs Market in Japan (2019-2027)
Table 26: Oncology Drugs Market in India (2019-2027)
Table 27: Oncology Drugs Market in Australia (2019-2027)
Table 28: Oncology Drugs Market in South Korea (2019-2027)
Table 29: Oncology Drugs Market in Rest of APAC (2019-2027)
Table 30: Oncology Drugs Market in Rest of World (2019-2027)
Table 31: Oncology Drugs Market in RoW by Region (2019-2027)
Table 32: Oncology Drugs Market in Middle East (2019-2027)
Table 33: Oncology Drugs Market in Africa (2019-2027)
Table 34: Oncology Drugs Market in South America (2019-2027)